214 related articles for article (PubMed ID: 35109863)
1. Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis.
Sánchez-Fernández A; Zandee S; Mastrogiovanni M; Charabati M; Rubbo H; Prat A; López-Vales R
J Neuroinflammation; 2022 Feb; 19(1):27. PubMed ID: 35109863
[TBL] [Abstract][Full Text] [Related]
2. Pro-resolution lipid mediator maresin-1 ameliorates inflammation, promotes neuroprotection, and prevents disease progression in experimental models of multiple sclerosis.
Zahoor I; Nematullah M; Ahmed ME; Fatma M; Mir S; Ayasolla K; Cerghet M; Palaniyandi S; Mao-Draayer Y; Rattan R; Giri S
bioRxiv; 2023 Sep; ():. PubMed ID: 37808700
[TBL] [Abstract][Full Text] [Related]
3. Maresin 1 Promotes Inflammatory Resolution, Neuroprotection, and Functional Neurological Recovery After Spinal Cord Injury.
Francos-Quijorna I; Santos-Nogueira E; Gronert K; Sullivan AB; Kopp MA; Brommer B; David S; Schwab JM; López-Vales R
J Neurosci; 2017 Nov; 37(48):11731-11743. PubMed ID: 29109234
[TBL] [Abstract][Full Text] [Related]
4. Pro-resolving lipid mediator lipoxin A
Derada Troletti C; Enzmann G; Chiurchiù V; Kamermans A; Tietz SM; Norris PC; Jahromi NH; Leuti A; van der Pol SMA; Schouten M; Serhan CN; de Vries HE; Engelhardt B; Kooij G
Cell Rep; 2021 Jun; 35(9):109201. PubMed ID: 34077725
[TBL] [Abstract][Full Text] [Related]
5. IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8.
Sánchez-Fernández A; Zandee S; Amo-Aparicio J; Charabati M; Prat A; Garlanda C; Eisenmesser EZ; Dinarello CA; López-Vales R
Theranostics; 2021; 11(1):1-13. PubMed ID: 33391457
[No Abstract] [Full Text] [Related]
6. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
7. Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis.
Kuo PC; Weng WT; Scofield BA; Paraiso HC; Brown DA; Wang PY; Yu IC; Yen JH
J Neuroinflammation; 2020 Apr; 17(1):138. PubMed ID: 32349768
[TBL] [Abstract][Full Text] [Related]
8. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
[TBL] [Abstract][Full Text] [Related]
9. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
[TBL] [Abstract][Full Text] [Related]
10. Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
Junqueira SC; Dos Santos Coelho I; Lieberknecht V; Cunha MP; Calixto JB; Rodrigues ALS; Santos ARS; Dutra RC
Mol Neurobiol; 2017 Jul; 54(5):3271-3285. PubMed ID: 27130268
[TBL] [Abstract][Full Text] [Related]
11. Maresin 1 Improves Cognitive Decline and Ameliorates Inflammation in a Mouse Model of Alzheimer's Disease.
Yin P; Wang X; Wang S; Wei Y; Feng J; Zhu M
Front Cell Neurosci; 2019; 13():466. PubMed ID: 31680874
[TBL] [Abstract][Full Text] [Related]
12. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
13. Anti-Inflammatory Effect of Specialized Proresolving Lipid Mediators on Mesenchymal Stem Cells: An In Vitro Study.
AlZahrani S; Shinwari Z; Gaafar A; Alaiya A; Al-Kahtani A
Cells; 2022 Dec; 12(1):. PubMed ID: 36611915
[TBL] [Abstract][Full Text] [Related]
14. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of the total saponin from Panax Japonicus on experimental autoimmune encephalomyelitis by attenuating inflammation and regulating gut microbiota in mice.
Wang J; He L; Wang S; Zhao H; Chen J; Dong Y; Yasen S; Wang L; Zou H
J Ethnopharmacol; 2023 Oct; 315():116681. PubMed ID: 37230280
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE).
Karampoor S; Zahednasab H; Bokharaei-Salim F; Mirzaei R; Mojallal-Tabatabaei Z; Esghaei M; Keyvani H
Int Immunopharmacol; 2020 Jan; 78():105943. PubMed ID: 31830622
[TBL] [Abstract][Full Text] [Related]
17. MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Mao P; Manczak M; Shirendeb UP; Reddy PH
Biochim Biophys Acta; 2013 Dec; 1832(12):2322-31. PubMed ID: 24055980
[TBL] [Abstract][Full Text] [Related]
18. 4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis.
Weng WT; Kuo PC; Brown DA; Scofield BA; Furnas D; Paraiso HC; Wang PY; Yu IC; Yen JH
J Neuroinflammation; 2021 May; 18(1):110. PubMed ID: 33975618
[TBL] [Abstract][Full Text] [Related]
19. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling.
Zhang D; Qiao L; Fu T
Biomed Pharmacother; 2020 May; 125():109528. PubMed ID: 32106388
[TBL] [Abstract][Full Text] [Related]
20. Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.
Zahoor I; Giri S
Clin Rev Allergy Immunol; 2021 Apr; 60(2):147-163. PubMed ID: 32495237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
